Pacol, Merilyn A.
HRN: 25-83-69 Sex: FemalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
09/06/2024
MUPIROCIN 2%, 15G (TUBE)
09/06/2024
09/13/2024
TOPICAL
As Needed
BID
Infected Wound
Waiting Final Action
Indication: ProphylaxisEmpiric Type of Infection: Skin & Soft Tissue Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes